Sprouts Farmers Market (SFM) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
19 Feb, 2026Executive summary
Achieved strong growth in FY2025 with net sales up 14% to $8.8B, comparable sales up 7.3%, and EPS up 42%, driven by new stores, loyalty program launch, and expanded self-distribution.
Opened 37 new stores in 2025, reaching 477 stores in 24 states by year-end, with new stores outperforming expectations.
Maintained a healthy balance sheet and robust cash flow, ending 2025 with $257M in cash and no long-term debt.
Continued execution of strategic initiatives, including loyalty program rollout and transition to self-distribution for meat and seafood.
Despite strong results, comp momentum slowed at year-end, with slightly negative Q4 traffic and increased consumer focus on affordability.
Financial highlights
Q4 2025 net sales were $2.1B, up 8% YoY; comparable store sales grew 1.6%.
Q4 diluted EPS was $0.92 (up 16-17% YoY); full-year diluted EPS was $5.31 (up 42% YoY).
FY2025 net income was $524M; EBITDA reached $843.9M.
Operating cash flow for 2025 was $716M; capital expenditures (net) were $224M.
Gross margin for 2025 was 38.8% (up 70 bps YoY); operating margin was 7.8%.
Outlook and guidance
FY2026 is a 53-week year; extra week expected to add $200M sales, $28M EBIT, $0.21 EPS.
FY2026 (52-week basis): total sales growth 4.5%-6.5%, comp sales -1% to +1%, EBIT $675M-$695M, EPS $5.28-$5.44.
At least 40 new stores planned for 2026; capex expected at $280M-$310M.
Q1 2026: comp sales -3% to -1%, EPS $1.66-$1.70, EBIT margin pressure of ~85 bps.
Share repurchases of at least $300M planned for 2026; $836M remains under current authorization.
Latest events from Sprouts Farmers Market
- Q2 net sales up 12%, EPS $0.94, and 35 new stores planned for 2024.SFM
Q2 20242 Feb 2026 - Accelerated growth, digital expansion, and loyalty initiatives drive strong performance.SFM
Goldman Sachs 31st Annual Global Retailing Conference22 Jan 2026 - Q3 net sales up 14%, EPS up 42%, margin gains, no debt, and $600M buyback underway.SFM
Q3 202417 Jan 2026 - Rapid growth and margin gains fueled by unique products, efficient operations, and omnichannel strategy.SFM
Presents at 51st Nasdaq London Investor Conference11 Jan 2026 - Double-digit sales and EPS growth in 2024, with strong 2025 outlook and expansion plans.SFM
Q4 20247 Jan 2026 - Growth is fueled by health-focused innovation, local sourcing, and a data-driven loyalty rollout.SFM
BofA Securities Consumer and Retail Conference 202526 Dec 2025 - Q1 2025 delivered 19% sales growth, 62% EPS gain, and record margins, with a strong outlook.SFM
Q1 20253 Dec 2025 - Annual meeting to vote on directors, pay, auditor, and board declassification amid strong results.SFM
Proxy Filing1 Dec 2025 - Shareholders to vote on board declassification, executive pay, and auditor ratification amid strong growth.SFM
Proxy Filing1 Dec 2025